Key result
ANG II type 1 receptor antagonist treatment during renal development led to progressive BP increments and renal damage, with a greater GFR decrease in males than females.
Altered renal development via ANG II type 1 receptor antagonism leads to sex-dependent progressive hypertension and renal damage in aged rats, with males being more severely affected than females.
Answers are grounded in this paper and cite their sources.
Suggests caution with developmental AT1 antagonism; hypothesis-generating for sex-specific renal programming in humans.
Numerous studies have evaluated blood pressure (BP) and renal changes in several models of developmental programming of hypertension. The present study examined to what extent BP, renal hemodynamic, and renal structure are affected at an old age in male and female animals with altered renal development. It also evaluated whether renal damage is associated with changes in cyclooxygenase (COX)-2 and neuronal nitric oxide synthase (NOS1) expression and immunoreactivity. Experiments were carried out in rats at 10-11 and 16-17 mo of age treated with vehicle or an ANG II type 1 receptor antagonist during the nephrogenic period (ARAnp). A progressive increment in BP and a deterioration of renal hemodynamics were found in both sexes of ARAnp-treated rats, with these changes being greater (P < 0.05) in male rats. The decrease in glomerular filtration rate at the oldest age was greater (P < 0.05) in male (74%) than female (32%) ARAnp-treated rats. Sex-dependent deterioration of renal structure was demonstrated in optical and electron microscopic experiments. COX-2 and NOS1 immunoreactivity were enhanced in the macula densa of male but not female ARAnp-treated rats. The present study reports novel findings suggesting that stimuli that induce a decrease of ANG II effects during renal development lead to a progressive increment in BP and renal damage at an old age in both sexes, but these BP and renal changes are greater in males than in females. The renal damage is associated with an increase of COX-2 and NOS1 in the macula densa of males but not females with altered renal development.
No takes yet. Share an insight, caveat, or question.
Sáez et al. (2014) studied Altered renal development. ANG II type 1 receptor antagonist (ARAnp) vs. Vehicle was evaluated on Decrease in glomerular filtration rate at the oldest age (p=<0.05). ANG II type 1 receptor antagonist treatment during renal development led to progressive BP increments and renal damage, with a greater GFR decrease in males than females.
Synapse has enriched 10 related papers. Consider them for comparative context: